Form 4: Ceribell Inc. Insider Trades: Director Sells Shares
Statement of Changes in Beneficial Ownership
Ceribell, Inc. Director Xingjuan Chao executed a series of stock transactions on May 5, 2026, including the sale of common stock and the exercise of stock options, as detailed in a Form 4 filing.
Summary
- Xingjuan Chao, a Director and President and CEO of Ceribell, Inc., reported several transactions on May 5, 2026.
- These transactions involved the sale of 14,000 shares of common stock at a weighted average price of $20.12, and the sale of 23,554 shares at a weighted average price of $20.09.
- Chao also acquired shares through the exercise of stock options, obtaining 1,446 shares at an exercise price of $4.70 and an additional 23,554 shares at the same price.
- Following these transactions, Chao beneficially owns 836,347 shares directly and 369,088 shares indirectly through the ACP 2021 Trust.
- The sales were conducted under a Rule 10b5-1 trading plan.
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a neutral to slightly negative filing due to the significant sale of shares by a key executive, despite the transactions being conducted under a pre-arranged trading plan.
Positives
- Xingjuan Chao acquired a total of 25,000 shares through the exercise of stock options at a favorable price of $4.70.
- The company has a Rule 10b5-1 trading plan in place, indicating a structured approach to insider trading.
Negatives
- Xingjuan Chao sold a significant number of shares, totaling 37,554 shares, indicating a reduction in direct ownership.
- The sale prices for the common stock were in the range of $19.77 to $20.48, suggesting a potential downward pressure on the stock if these sales are substantial relative to trading volume.
Risks
- The sale of a large number of shares by a key executive could be interpreted negatively by the market, potentially impacting investor confidence.
- The Rule 10b5-1 trading plan, while providing a defense against insider trading allegations, still represents a disposition of company stock by an insider.
Future Outlook
The filing does not contain forward-looking statements or guidance. It solely reports past transactions.
Management Comments
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.77 to $20.48, inclusive.
- The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote.
- The Reporting Person is a co-trustee of the ACP 2021 Trust, and therefore may be deemed to share beneficial ownership of these securities.
- The Reporting Person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein.
- The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of April 1, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
- The stock option is fully vested and currently exercisable.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions. The execution of trades under a Rule 10b5-1 plan is a common practice for executives to diversify their holdings while adhering to regulatory requirements. The specific details of the sales and option exercises provide insight into insider activity at Ceribell, Inc.
Stakeholder Impact
- Shareholders may view the sale of shares by a Director and CEO with caution, potentially leading to short-term price pressure.
- Employees whose stock options are tied to continued employment may be reassured by the exercise of options, but the sales could also signal a lack of strong conviction from leadership regarding immediate stock appreciation.
Next Steps
- Continued monitoring of insider transactions for further insights into executive sentiment and potential future stock movements.
- Observe the market's reaction to these reported transactions.
Key Dates
| Date | Description |
|---|---|
| 04/01/2023 | Start date for monthly vesting of a portion of stock options. |
| 05/05/2026 | Date of reported stock transactions (sales and option exercises). |
| 05/07/2026 | Date of filing for Form 4. |
| 02/16/2033 | Expiration date for certain stock options. |
Recommendation
holdThe filing reports routine insider transactions under a 10b5-1 plan, which includes both sales and option exercises. While the sales represent a reduction in direct ownership by a key executive, the structured nature of the plan mitigates concerns about opportunistic selling. The exercise of options at a lower price point is a positive indicator for the executive's personal investment. Without additional financial or strategic information, a 'hold' recommendation is appropriate, pending further developments.
Keywords
Form 4, Insider Trading, Stock Options, Common Stock, Beneficial Ownership, Rule 10b5-1, Ceribell Inc., CBLL, Xingjuan Chao, Director, CEO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.